Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK
about
Recent developments in esophageal adenocarcinomaSurgical indications and optimization of patients for resectable esophageal malignanciesRecent developments in pathogenesis, diagnosis and therapy of Barrett's esophagusAcid suppressive drugs and gastric cancer: a meta-analysis of observational studiesEtiology and Prevention of Esophageal CancerEnvironmental causes of esophageal cancerThe changing face of esophageal cancerNature meets nurture: molecular genetics of gastric cancer.Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesisMedications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus.Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysisChemoprevention of esophageal adenocarcinomaAre We Making Progress in Preventing Barrett's-Related Esophageal Cancer?Risk of esophagus cancer in diabetes mellitus: a population-based case-control study in TaiwanExposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data.NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus.Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control studyAmerican Gastroenterological Association technical review on the management of Barrett's esophagusExposure to bisphosphonates and risk of cancer: a protocol for nested case-control studies using the QResearch primary care database.Acid inhibitory medication and risk of gastric and oesophageal cancerGastric carcinomas localized to the cardia.Barrett's Esophagus: Emerging Knowledge and Management StrategiesEpidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible?Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis.Barrett esophagus: what a mouse model can teach us about human diseaseAn automated tool for detecting medication overuse based on the electronic health records.Chemoprevention of gastrointestinal cancer: the reality and the dream.Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.Progression of Barrett's esophagus toward esophageal adenocarcinoma: an overviewNaproxen Twice Daily Versus as Needed (PRN) Dosing: Efficacy and Tolerability for Treatment of Acute Ankle Sprain, a Randomized Clinical Trial.Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus.The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.Barrett's esophagus: best practices for treatment and post-treatment surveillance.Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis.Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer.Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma.The role of inflammation in cancer of the esophagus.Obesity and related risk factors in gastric cardia adenocarcinoma.Potential mechanism of corpus-predominant gastritis after PPI therapy in Helicobacter pylori-positive patients with GERD
P2860
Q26849652-F3088ACF-C536-446B-B29E-64A938966028Q26861000-AA6236BA-3BBA-408D-AFBB-563FBD5D89F2Q26864783-C7A0D753-6104-4E07-9E1E-29C9D87C8165Q27025101-070F4091-2DCA-4787-B212-584161705F99Q28077495-BF9448A8-CBA5-4AA8-A461-12718EEDDFD8Q28388848-5120A80D-DB3E-460D-B30C-F0D492B1BE97Q28391577-28BA6B19-8754-47A3-B6F7-EF71D1D749C8Q33347546-981C413B-0C71-4436-A728-8B04CCBF3349Q33863317-878B0F5B-0785-4D09-9CE7-3F3F1AABC247Q33905941-408B9241-4589-4074-B05D-F78977C5CDA7Q34352867-C4C84190-578C-4FCB-B90C-9300A7496896Q34408890-8D8598D2-D359-4C12-94FF-E99A57482058Q34408973-C0B6FB52-1603-4C61-8166-074DDA0B47B4Q34509469-4A1E6D06-66E4-43D4-8611-265A616453A3Q34550590-30C2957C-50CD-49FA-8363-B51533225B6BQ35046884-BCA0BD95-3F3A-4DA1-B34D-76EED3807993Q35116562-918E808A-885E-4FC1-9392-18660B234C5CQ35653793-F463E851-97E9-4C11-9E47-AC9F8B46AE1FQ35673305-813D423E-756A-484A-BB7B-CF1E5452D71DQ35753917-619C65EA-D919-43ED-B046-5E0AFE8A77A7Q35769164-EA4A5050-5E8D-404C-932A-E9BB17AFFCFFQ35821499-C93DCDC5-8CF9-46CF-8150-36F1016719F3Q36014649-C667E5FF-E146-4ACD-AA28-3BF260C5402EQ36117678-07410350-32E8-486C-9DF5-84F853EAB82EQ36245569-33502F71-75CE-4E90-8DCA-4013222AFE05Q36556299-D41A1503-BF6F-44C4-A689-BF8C39DD2DFEQ36592533-70120A1E-7D25-4867-BD22-0302C9BA6370Q36715105-71D6AE95-8FCC-4E1D-A5F3-F4EE1485D799Q37222668-41B7966E-1460-4810-B930-676F94378943Q37542809-CEF77517-DA9F-4BCA-9B0C-2C942C8F8FDFQ37687478-DF99DA6F-3D55-4BF3-8FAB-11B08BB9C4BEQ37702201-C911AA8B-0DB5-4CEC-8732-830D8430B988Q37709906-1D682C73-77A8-4FAC-AD5E-3D8FFE48A926Q37747384-38DB9C34-CE79-4A0D-860B-51C33CBAD7E8Q37794231-69EF660B-1915-46A2-A3E6-A9B6426B0960Q37830358-99279E20-7238-44F4-9A07-43E342EA46F8Q38084154-D265A8DE-22E3-4530-B100-1F239A42777FQ38214324-4F86B9C8-35FF-44C6-B679-70B0AF4C5777Q38248208-5FCB77CA-F003-45AE-B899-DBA56F877240Q38251488-C9E66DBB-0A6A-440C-8CA1-4342D4534604
P2860
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Gastric acid suppression and r ...... d case control study in the UK
@en
Gastric acid suppression and r ...... d case control study in the UK
@nl
type
label
Gastric acid suppression and r ...... d case control study in the UK
@en
Gastric acid suppression and r ...... d case control study in the UK
@nl
prefLabel
Gastric acid suppression and r ...... d case control study in the UK
@en
Gastric acid suppression and r ...... d case control study in the UK
@nl
P2860
P356
P1433
P1476
Gastric acid suppression and r ...... d case control study in the UK
@en
P2093
L A García Rodríguez
M Lindblad
P2860
P304
P356
10.1136/GUT.2005.086579
P407
P577
2006-06-19T00:00:00Z